Role of interleukin‐6 signalling in glucose and lipid metabolism
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Derangements in whole body glucose and lipid metabolism, accompanied by insulin resistance, are key features of obesity and the metabolic syndrome. A role for inflammation as a causative factor is an emerging concept in the field of metabolic disease. Research has centred on identifying important inflammatory markers, and tumour necrosis factor‐α has been highlighted as a key mediator of insulin resistance, as well as interleukin‐6 (IL‐6). A parallel ongoing endeavour is the unravelling of molecular mechanisms underlying the beneficial effects of physical exercise on whole body glucose and lipid metabolism. Release of IL‐6 from the contracting skeletal muscle has been proposed to be one of the molecular signals promoting the beneficial exercise‐induced effects. These two opposing views of IL‐6 underscore that the role of IL‐6 in whole body physiology is incompletely resolved. This review aims at summarizing the current data on mechanisms by which IL‐6 may impact on glucose and lipid metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 2×
“The incidence of obesity is growing dramatically in the United States, Europe and Worldwide (Li et al. 2006, WHO, 2006), which in turn is increasing the number of people with type 2 diabetes in an epidemic-like fashion (Zimmet et al. 2001).”
BackgroundC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“IRS1 and PKB/Akt are critical nodes in the canonical insulin signalling pathway; a cascade of phosphorylation events initiated by insulin receptor autophosphorylation, and comprising a number of signalling molecules, including PI 3-kinase and AS160 (Glund & Zierath 2005, Taniguchi et al. 2006).”
BackgroundThe Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245 · cited 3×
“A less extreme elevation of IL-6 (six to ninefold over wildtype levels) resulted in a diabetic phenotype (Cai et al. 2005) or hepatic insulin resistance (Kim et al. 2004).”
BackgroundProtection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234 · cited 2×
“Some recent studies have highlighted that one of the main functions of IL-6 is to dampen the inflammatory response, primarily by suppressing the production of tumour necrosis factor-a (TNF-a) and IL-1b (Schindler et al. 1990, Tilg et al. 1994, Xing et al. 1998, Starkie et al. 2003, Steensberg et al. 2003).”
ResultImpaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Kern, P. A., Ranganathan, S., Li, C., Wood, L., & Ranganathan, G. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e745 · Cited by 1,883 · cited 2×
“Several different tissues contribute to basal circulating IL-6 levels, with up to 35% coming from adipose tissue (Mohamed-Ali et al. 1997, Kern et al. 2001).”
BackgroundInflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Cited by
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Pedersen, B. K. (2011) · Journal of Experimental Biology · doi:10.1242/jeb.048074 · Cited by 668
Cardiovascular comorbidity in rheumatic diseases
Nurmohamed, M. T., Heslinga, M., & Kitas, G. D. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.112 · Cited by 325
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G. T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R. E., Kern, P. A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90885.2008 · Cited by 229
Hübner, M., Mantziari, S., Demartines, N., Pralong, F., Coti-Bertrand, P., & Schäfer, M. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/8743187 · Cited by 191
Metadata
- Authors
- Glund, S., & Krook, A.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2007-10-29
- Volume
- 192
- Issue
- 1
- Pages
- 37-48
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2155959568
- Cited by
- 126
- References
- 42
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of interleukin‐6 signalling in glucose and lipid metabolism. https://app.cochat.ai/papers/10.1111/j.1748-1716.2007.01779.x
- The paper
- Glund, S., & Krook, A. (2008). Role of interleukin‐6 signalling in glucose and lipid metabolism. Acta Physiologica. https://doi.org/10.1111/j.1748-1716.2007.01779.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.